Alnylam Pharmaceuticals (ALNY) Revenue by Segment

History

Date	Amvuttra	Givlaari	Royalty	Oxlumo	Collaboration	Onpattro
Dec 31, 2025	2.31B	308.49M	174.02M	191.44M	553.37M	172.79M
Sep 30, 2025	1.77B	286.34M	148.04M	185.36M	619.37M	197.21M
Jun 30, 2025	1.35B	283.46M	125.23M	172.73M	325.03M	208.43M
Mar 31, 2025	1.09B	264.71M	107.65M	166.46M	490.83M	233.09M
Dec 31, 2024	970.41M	255.85M	91.79M	166.97M	510.15M	252.80M
Sep 30, 2024	859.20M	250.50M	73.40M	156.10M	479.60M	275.70M
Jun 30, 2024	749.30M	233.60M	59.90M	144.60M	849.70M	307.00M
Mar 31, 2024	651.30M	229.40M	44.70M	128.20M	628.20M	321.30M
Dec 31, 2023	557.90M	219.20M	40.60M	109.80M	546.20M	354.60M
Sep 30, 2023	451.20M	207.00M	26.30M	100.90M	540.40M	397.80M
Jun 30, 2023	327.70M	198.60M	19.10M	88.60M	142.20M	461.20M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.